Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Corrigendum: Testosterone Replacement Therapy and Cardiovascular Risk: A Review

Corona G, Rastrelli , Maseroli E, Sforza A, Maggi M

In published article by Corona G et al., an author's name was misspelled.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Testosterone Replacement Therapy: Long-Term Safety and Efficacy

Corona G, Sforza A, Maggi M

Recent position statements and guidelines have raised the distinction between a true and false, age-related hypogonadism (HG) or late-onset hypogonadism (LOH). The former is the consequence of congenital or acquired...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Testosterone Replacement Therapy and Cardiovascular Risk: A Review

Corona G G, Rastrelli , Maseroli E, Sforza A, Maggi M

Recent reports in the scientific and lay press have suggested that testosterone (T) replacement therapy (TRT) is likely to increase cardiovascular (CV) risk. In a final report released in 2015,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risks and Benefits of Late Onset Hypogonadism Treatment: An Expert Opinion

Corona G, Vignozzi L, Sforza A, Maggi M

  • KMID: 2320839
  • World J Mens Health.
  • 2013 Aug;31(2):103-125.
Late-onset hypogonadism (LOH) is a syndromic condition that has a well-recognized association with sexual and reproductive failure. LOH is frequently associated with chronic conditions including cardiovascular diseases (CVD), obesity, osteoporosis,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Testosterone Deficiency and Risk of Cognitive Disorders in Aging Males

Corona G, Guaraldi F, Rastrelli G, Sforza A, Maggi M

Cognitive impairment and dementia are predicted to undergo a dramatic increase in the following years with more than 131.5 million people being affected by 2030. Although vascular diseases play the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Functional Hypogonadism Besides Pharmacological Substitution

Corona G, Rastrelli G, Morelli A, Sarchielli E, Cipriani S, Vignozzi L, Maggi M

A dichotomic distinction between “organic” and “functional” hypogonadism is emerging. The former is an irreversible condition due to congenital or “acquired” “organic” damage of the brain centers or of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective

Corona G, Rastrelli G, Marchiani S, Filippi S, Morelli A, Sarchielli E, Sforza A, Vignozzi L, Maggi M

The real epidemiology and the possible consequences of anabolic-androgenic steroids (AAS) use still represent a very tricky task due to the difficulties in the quantification and detection of these drugs....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer

Corona G, Filippi S, Bianchi N, Dicuio M, Rastrelli G, Concetti S, Sforza A, Maggi M

Androgen deprivation therapy (ADT) is the gold standard treatment in patients with locally advanced or metastatic prostate cancer (PC). Emerging evidence has documented a tight association between ADT and body...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr